Prostate Cancer Foundation Becomes VA Partner to Further Clinical Research
The Department of Veterans Affairs’ (VA) latest strategic partnership with the Prostate Cancer Foundation (PCF) aims to improve cancer care and research for both veterans and civilians.
The PCF will contribute $50 million in funding to back a “precision oncology initiative” to expand cancer care to veterans. This initiative will, in turn, help the PCF and VA clinicians develop new treatment options and potentially find a cure.
The PCF partnership hopes to increase:
- How many Veterans Health Administration (VHA) investigators are applying for PCF funding.
- The number of VHA facilities performing precision medicine and prostate cancer clinical trials.
- Veterans enrolled in clinical trials, studies, or providing data and samples to existing studies.
- Minorities involved in PCF studies.
- Scientists studying prostate cancer early in their career.
According to VA records, doctors diagnose approximately 12,000 veterans with prostate cancer every year. Prostate cancer is the most frequently diagnosed cancer among veterans, and it is especially prevalent in African-American veterans.
The new partnership and its results will not only benefit veterans with cancer. The VA and PCF hope that through their combined efforts they can develop new treatment methods and cures for all people with prostate cancer.
Prostate Cancer Might Qualify You for Veterans’ Disability Benefits
Many types of cancer will qualify you for veterans’ disability benefits. However, qualifying requires that you prove you developed cancer due to exposure to a carcinogenic substance during your service. The VA has linked chemicals such as Agent Orange to the development of certain cancers, and scientists are discovering new service-related cancers as research continues.
If you want to know more about your right to disability benefits through the VA, call the Disability Help Group at 800-800-2009 to schedule a free consultation with one of our disability advocates today.